Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy

Journal of Clinical Oncology

Volumn 14, Issue 9, 1996, Pages 2584-2589

  Kuukasjarvi T ^a   Kononen, J ^a   Helin, H ^a   Holli, K ^a   Isola, J ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER HORMONE THERAPY; CANCER RECURRENCE; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HORMONE RECEPTOR INTERACTION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECEPTOR AFFINITY;

EID: 0029781863     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.9.2584     Document Type: Article

References (33)

1. Hahnel R: Progesterone receptor assay in the management of breast and other cancers. Rev Endocr Rel Cancer 20:5-11, 1985
2. McGuire WL, Clark GM: Role of progesterone receptors in breast cancer. Semin Oncol 12:12-16, 1985
3. Howell A, Harland RN, Bramwell VHC, et al: Steroid-hormone receptors and survival after relapse in breast cancer. Lancet 17:588-591, 1984
4. Shek LL, Godolphin W: Survival with breast cancer: The importance of estrogen receptor quantity. Eur J Cancer Clin Oncol 25:243-250, 1989
5. Koenders PG, Beex LV, Kloppenborg PW, et al: Human breast cancer: Survival from first metastasis. Breast Cancer Study Group. Breast Cancer Res Treat 21:173-180, 1992
6. Clark GM, McGuire WL: Progesterone receptors and human breast cancer. Breast Cancer Res Treat 3:157-169, 1983
7. Osborne CK, Yochmowitz MG, Knight WA, et al: The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 46:2884-2888, 1984
8. Muss HB, Thor AD, Berry DA, et al: c-erbB2 expression and response to adjuvant therapy in women with node-positive early breast cancer. N Engl J Med 330:1260-1266, 1994
9. Fuqua SA: Estrogen receptor mutagenesis and hormonal resistance. Cancer 74:1026-1029, 1994
10. Sluyser M: Mutations in the estrogen receptor gene. Hum Mutat 6:97-103, 1995
11. Castles CG, Fuqua SA, Klotz DM, et al: Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 breast cancer cell line. Cancer Res 53:5934-5939, 1993
12. Allegra JC, Barlock A, Karen RN, et al: Changes in multiple or sequential estrogen receptor determination in breast cancer. Cancer 45:792-794, 1980
13. Hawkins RA, Tesdale EDC, Anderson PA, et al: Does the oestrogen receptor concentration of a breast cancer change during systemic therapy? Br J Cancer 61:877-880, 1990
14. Johnston SDR, Saccani-Jotti G, Smith IE, et al: Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer. Cancer Res 55:3331-3338, 1995
15. Brennan MJ, Donegan WL, Appleby DE: The variability of estrogen receptors in metastatic breast cancer. Am J Surg 137:260-262, 1979
16. Holdaway IM, Fracp MD, Bowditch BSc: Variation in receptor status between primary and metastatic breast cancer. Cancer 52:479-485, 1983
17. Rasmussen BB, Kamby C: Immunohistochemical detection of estrogen receptors in paraffin sections from primary and metastatic breast cancer. Pathol Res Pract 185:856-859, 1989
18. Hull DF, Clark GM, Osborne CK, et al: Multiple estrogen receptor assays in human breast cancer. Cancer Res 43:413-416, 1983
19. Raemaekers JM, Beex LV, Koenders AJ, et al: Concordance and discordance of estrogen and progesterone receptor content in sequential biopsies of patients with advanced breast cancer. Relation to survival. Eur J Cancer Clin Oncol 20:1011-1018, 1984
20. Hartmann WH, Ozzello L, Sobin LH, et al (eds): Histological Typing of Breast Tumors (ed 2). Geneva, Switzerland, World Health Organization, 1981, pp 15-25
21. Morgan JM, Navabi H, Schmid KW, et al: Possible role of tissue-bound calsium ions in citrate-mediated high-temperature antigen retrieval. J Pathol 174:301-307, 1994
22. Peacock CS, Thompson IW, Van Noorden S: Silver enhancement of polymerised diaminobenzidine: Increased sensitivity for immunoperoxidase staining. J Clin Pathol 44:756-758, 1991
23. Green S, Walter P, Kurnar V, et al: Human oestrogen receptor cDNA: Sequence, expression and homology to v-erb-A. Nature 320:134-139, 1986
24. Dagerlind Å, Friberg K, Bean AJ, et al: Sensitive messenger RNA detection using unfixed tissue-combined radioactive and nonradioactive in situ hybridization histochemistry. Histochemistry 98:39-49, 1992
25. Pelto-Huikko M, Dagerlind Å, Kononen J, et al: Neuronal regulation of C-fos, C-jun and junB immediate-early genes in rat adrenal medulla. J Neurosci 15:1854-1868, 1995
26. Osborne CK: Heterogeneity in hormone receptor status in primary and metastatic breast cancer. Semin Oncol 12:317-326, 1985
27. Fisher B, Redmont C, Brown A, et al: Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer: 5-year results from the National Surgical Adjuvant Breast and Bowel Project trial. J Clin Oncol 4:459-471, 1986
28. Lippman ME, Cassidy J, Wesley M, et al: A randomized attempt to increase the efficacy of cytotoxic chemotherapy in metastatic breast cancer by hormonal synchronization. J Clin Oncol 2:28-36, 1984
29. Flowers JL, Burton GV, Cox EB, et al: Use of monoclonal antibody to evaluate estrogen receptor content in fine needle aspiration biopsies. Ann Surg 203:250-254, 1986
30. Magdelenat H, Merle S, Zajdela A: Enzyme immunoassay of estrogen receptors in fine needle aspirates of breast tumors. Cancer Res 46:4265-4267, 1986
31. Roodi N, Bailey LR, Kao WY, et al: Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative breast cancer. J Natl Cancer Inst 87:446-451, 1995
32. Iwase H, Greenman JM, Barnes DM, et al: Loss of heterozygosity of the estrogen receptor gene in breast cancer. Br J Cancer 71:448-450, 1995
33. Sluyser M: Hormone Resistance in cancer: The role of abnormal steroid receptors. Crit Rev Oncol 5:539-554, 1994